Research advances in hereditary pancreatitis in children

Abstract

Hereditary pancreatitis （HP） is one of the major causes of pancreatitis in children and has a high risk of carcinogenesis after they become adults. This article reviews the recent research advances in HP， including historical development， epidemiology， pathogenic mechanism， and related pathogenic genes， clinical features， and diagnosis and treatment， in order to provide new reference information for delaying the progression of HP in children and conducting related basic research.
- Hereditary Pancreatitis,
- Signs and Symptoms,
- Therapeutics,
- Child

FullText(HTML)

References(49)

References

[1]	LE COSQUER G, MAULAT C, BOURNET B, et al. Pancreatic cancer in chronic pancreatitis: Pathogenesis and diagnostic approach[J]. Cancers(Basel), 2023, 15( 3): 761. DOI: 10.3390/cancers15030761.
[2]	TAN M, SCHAFFALITZKY de MUCKADELL OB, JØRGENSEN MT. Hereditary pancreatitis[J]. Ugeskr Laeger, 2020, 182( 7): V 11190676.
[3]	COLLETT RW, KENNEDY RL. Chronic relapsing pancreatitis associated with hyperlipemia in an eight year old boy[J]. Proc Staff Meet Mayo Clin, 1948, 23( 7): 158- 162.
[4]	COMFORT MW, STEINBERG AG. Pedigree of a family with hereditary chronic relapsing pancreatitis[J]. Gastroenterology, 1952, 21( 1): 54- 63.
[5]	KEIM V, BAUER N, TEICH N, et al. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene[J]. Am J Med, 2001, 111( 8): 622- 626. DOI: 10.1016/s0002-9343(01)00958-5.
[6]	PAOLINI O, HASTIER P, BUCKLEY M, et al. The natural history of hereditary chronic pancreatitis: a study of 12 cases compared to chronic alcoholic pancreatitis[J]. Pancreas, 1998, 17( 3): 266- 271. DOI: 10.1097/00006676-199810000-00007.
[7]	LE BODIC L, SCHNEE M, GEORGELIN T, et al. An exceptional genealogy for hereditary chronic pancreatitis[J]. Dig Dis Sci, 1996, 41( 7): 1504- 1510. DOI: 10.1007/BF02088580.
[8]	WHITCOMB DC, PRESTON RA, ASTON CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35[J]. Gastroenterology, 1996, 110( 6): 1975- 1980. DOI: 10.1053/gast.1996.v110.pm8964426.
[9]	WHITCOMB DC, GORRY MC, PRESTON RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene[J]. Nat Genet, 1996, 14( 2): 141- 145. DOI: 10.1038/ng1096-141.
[10]	FÉREC C, RAGUÉNÈS O, SALOMON R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis[J]. J Med Genet, 1999, 36( 3): 228- 232.
[11]	REBOURS V, BOUTRON-RUAULT MC, SCHNEE M, et al. The natural history of hereditary pancreatitis: a national series[J]. Gut, 2009, 58( 1): 97- 103. DOI: 10.1136/gut.2008.149179.
[12]	LI MY, YANG J. Research advances in hereditary pancreatitis[J/CD]. Chin J Gastrointest Endosc(Electronic Editon), 2018, 5( 2): 87- 92. DOI: 10.3877/cma.j.issn.2095-7157.2018.02.010. 李明阳, 杨晶. 遗传性胰腺炎的研究进展[J/CD]. 中华胃肠内镜电子杂志, 2018, 5( 2): 87- 92. DOI: 10.3877/cma.j.issn.2095-7157.2018.02.010.
[13]	SULTAN M, WERLIN S, VENKATASUBRAMANI N. Genetic prevalence and characteristics in children with recurrent pancreatitis[J]. J Pediatr Gastroenterol Nutr, 2012, 54( 5): 645- 650. DOI: 10.1097/MPG.0b013e31823f0269.
[14]	WANG W, SUN XT, WENG XL, et al. Comprehensive screening for PRSS1, SPINK1, CFTR, CTRC and CLDN2 gene mutations in Chinese paediatric patients with idiopathic chronic pancreatitis: A cohort study[J]. BMJ Open, 2013, 3( 9): e003150. DOI: 10.1136/bmjopen-2013-003150.
[15]	SZABÓ A, SAHIN-TÓTH M. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C[J]. J Biol Chem, 2012, 287( 24): 20701- 20710. DOI: 10.1074/jbc.M112.360065.
[16]	GORRY MC, GABBAIZEDEH D, FUREY W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis[J]. Gastroenterology, 1997, 113( 4): 1063- 1068. DOI: 10.1053/gast.1997.v113.pm9322498.
[17]	SUZUKI M, MINOWA K, NAKANO S, et al. Genetic abnormalities in pancreatitis: An update on diagnosis, clinical features, and treatment[J]. Diagnostics(Basel), 2020, 11( 1): 31. DOI: 10.3390/diagnostics11010031.
[18]	KUME K, MASAMUNE A, ARIGA H, et al. Do genetic variants in the SPINK1 gene affect the level of serum PSTI?[J]. J Gastroenterol, 2012, 47( 11): 1267- 1274. DOI: 10.1007/s00535-012-0590-3.
[19]	SCHNEIDER A. Serine protease inhibitor kazal type 1 mutations and pancreatitis[J]. Clin Lab Med, 2005, 25( 1): 61- 78. DOI: 10.1016/j.cll.2004.12.005.
[20]	FELDERBAUER P, HOFFMANN P, EINWÄCHTER H, et al. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations[J]. BMC Gastroenterol, 2003, 3: 34. DOI: 10.1186/1471-230X-3-34.
[21]	BEER S, ZHOU J, SZABÓ A, et al. Comprehensive functional analysis of chymotrypsin C(CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk[J]. Gut, 2013, 62( 11): 1616- 1624. DOI: 10.1136/gutjnl-2012-303090.
[22]	FINK EN, KANT JA, WHITCOMB DC. Genetic counseling for nonsyndromic pancreatitis[J]. Gastroenterol Clin North Am, 2007, 36( 2): 325- 333, ix. DOI: 10.1016/j.gtc.2007.03.007.
[23]	PANCHOO AV, VANNESS GH, RIVERA-RIVERA E, et al. Hereditary pancreatitis: An updated review in pediatrics[J]. World J Clin Pediatr, 2022, 11( 1): 27- 37. DOI: 10.5409/wjcp.v11.i1.27.
[24]	HASAN A, MOSCOSO DI, KASTRINOS F. The Role of genetics in pancreatitis[J]. Gastrointest Endosc Clin N Am, 2018, 28( 4): 587- 603. DOI: 10.1016/j.giec.2018.06.001.
[25]	WHITCOMB DC, LARUSCH J, KRASINSKAS AM, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis[J]. Nat Genet, 2012, 44( 12): 1349- 1354. DOI: 10.1038/ng.2466.
[26]	MUDDANA V, LAMB J, GREER JB, et al. Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: Role of serine protease inhibitor Kazal 1type and alcohol[J]. World J Gastroenterol, 2008, 14( 28): 4486- 4491. DOI: 10.3748/wjg.14.4486.
[27]	LUO X, WU ZX, LIU QC, et al. Clinical and hereditary characteristics of hereditary pancreatitis: An analysis of 13 cases[J]. World Chin J Dig, 2008, 16( 19): 2188- 2190. DOI: 10.3969/j.issn.1009-3079.2008.19.023. 骆休, 吴志雄, 刘奇才, 等. 遗传性胰腺炎临床和遗传特点分析13例[J]. 世界华人消化杂志, 2008, 16( 19): 2188- 2190. DOI: 10.3969/j.issn.1009-3079.2008.19.023.
[28]	WANG ZK, LI W. Progress in the diagnosis and treatment of hereditary pancreatitis[J]. Chin J Gastroenterol Hepatol, 2019, 28( 6): 711- 713. DOI: 10.3969/j.issn.1006-5709.2019.06.026. 王子恺, 李闻. 遗传性胰腺炎诊治进展[J]. 胃肠病学和肝病学杂志, 2019, 28( 6): 711- 713. DOI: 10.3969/j.issn.1006-5709.2019.06.026.
[29]	KOLODZIEJCZYK E, JURKIEWICZ E, PERTKIEWICZ J, et al. MRCP versus ERCP in the evaluation of chronic pancreatitis in children: Which is the better choice?[J]. Pancreas, 2016, 45( 8): 1115- 1119. DOI: 10.1097/MPA.0000000000000644.
[30]	GORDON K, CONWAY J, EVANS J, et al. EUS and EUS-guided interventions alter clinical management in children with digestive diseases[J]. J Pediatr Gastroenterol Nutr, 2016, 63( 2): 242- 246. DOI: 10.1097/MPG.0000000000001101.
[31]	ELLIS I, LERCH MM, WHITCOMB DC, et al. Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues[J]. Pancreatology, 2001, 1( 5): 405- 415. DOI: 10.1159/000055840.
[32]	WANG ZP, JING GX, LUO HH, et al. Efficacy and safety of aggressive fluid resuscitation versus conventional fluid resuscitation in early treatment of acute pancreatitis: A Meta-analysis[J]. J Clin Hepatol, 2023, 39( 9): 2158- 2168. DOI: 10.3969/j.issn.1001-5256.2023.09.019. 王张鹏, 景光旭, 罗欢欢, 等. 早期积极液体复苏与常规液体复苏治疗急性胰腺炎效果及安全性的Meta分析[J]. 临床肝胆病杂志, 2023, 39( 9): 2158- 2168. DOI: 10.3969/j.issn.1001-5256.2023.09.019.
[33]	SMIT M, BUDDINGH KT, BOSMA B, et al. Abdominal compartment syndrome and intra-abdominal ischemia in patients with severe acute pancreatitis[J]. World J Surg, 2016, 40( 6): 1454- 1461. DOI: 10.1007/s00268-015-3388-7.
[34]	ZHAO H, HAN Y, PENG KR, et al. Nasogastric or nasojejunal feeding in pediatric acute pancreatitis: A randomized controlled trial[J]. World J Pediatr, 2021, 17( 5): 536- 543. DOI: 10.1007/s12519-021-00441-0.
[35]	ZHU GY, WANG CM, LIAO SY, et al. Interpretation of clinical nutrition guidelines to acute and chronic pancreatitis by the European Society for Clinical Nutrition and Metabolism in 2020[J]. Chin J Pract Surg, 2020, 40( 11): 1259- 1262. DOI: 10.19538/j.cjps.issn1005-2208.2020.11.08. 朱桂英, 王长淼, 廖诗瑶, 等. 2020年《欧洲临床营养和代谢学会急慢性胰腺炎临床营养指南》解读[J]. 中国实用外科杂志, 2020, 40( 11): 1259- 1262. DOI: 10.19538/j.cjps.issn1005-2208.2020.11.08.
[36]	Section of Hepatobiliary Surgery, Branch of Pediatric Surgery, Chinese Medical Association. Expert consensus on diagnosing and treating chronic pancreatitis in children(2023)[J]. Chin J Pediatr Surg, 2023, 44( 7): 577- 585. DOI: 10.3760/cma.j.cn421158-20230111-00009. 中华医学会小儿外科学分会肝胆外科学组. 小儿慢性胰腺炎诊断与治疗专家共识(2023)[J]. 中华小儿外科杂志, 2023, 44( 7): 577- 585. DOI: 10.3760/cma.j.cn421158-20230111-00009.
[37]	ZELLO GA. Dietary reference intakes for the macronutrients and energy: Considerations for physical activity[J]. Appl Physiol Nutr Metab, 2006, 31( 1): 74- 79. DOI: 10.1139/h05-022.
[38]	MATEL JL. Nutritional management of cystic fibrosis[J]. JPEN J Parenter Enteral Nutr, 2012, 36( 1 Suppl): 60S- 67S. DOI: 10.1177/0148607111420156.
[39]	ARVANITAKIS M, OCKENGA J, BEZMAREVIC M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr, 2020, 39( 3): 612- 631. DOI: 10.1016/j.clnu.2020.01.004.
[40]	HEIJERMAN HG, LAMERS CB, BAKKER W. Omeprazole enhances the efficacy of pancreatin(pancrease) in cystic fibrosis[J]. Ann Intern Med, 1991, 114( 3): 200- 201. DOI: 10.7326/0003-4819-114-3-200.
[41]	FREEMAN AJ, MAQBOOL A, BELLIN MD, et al. Medical management of chronic pancreatitis in children: A position paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee[J]. J Pediatr Gastroenterol Nutr, 2021, 72( 2): 324- 340. DOI: 10.1097/MPG.0000000000003001.
[42]	LI ZS, WANG W, LIAO Z, et al. A long-term follow-up study on endoscopic management of children and adolescents with chronic pancreatitis[J]. Am J Gastroenterol, 2010, 105( 8): 1884- 1892. DOI: 10.1038/ajg.2010.85.
[43]	AGARWAL J, NAGESHWAR REDDY D, TALUKDAR R, et al. ERCP in the management of pancreatic diseases in children[J]. Gastrointest Endosc, 2014, 79( 2): 271- 278. DOI: 10.1016/j.gie.2013.07.060.
[44]	Chronic Pancreatitis Group of Pancreatic Disease Committee of Chinese Medical Doctor Association. Guideline for the diagnosis and treatment of chronic pancreatitis(2018, Guangzhou)[J]. J Clin Hepatol, 2019, 35( 1): 45- 51. DOI: 10.3969/j.issn.1001-5256.2019.01.008. 中国医师协会胰腺病专业委员会慢性胰腺炎专委会. 慢性胰腺炎诊治指南(2018, 广州)[J]. 临床肝胆病杂志, 2019, 35( 1): 45- 51. DOI: 10.3969/j.issn.1001-5256.2019.01.008.
[45]	KOHOUTOVA D, TRINGALI A, PAPPARELLA G, et al. Endoscopic treatment of chronic pancreatitis in pediatric population: Long-term efficacy and safety[J]. United European Gastroenterol J, 2019, 7( 2): 270- 277. DOI: 10.1177/2050640618817699.
[46]	QIN XM, ZHANG J, YU FH, et al. Application of endoscopic retrograde cholangiopancreatography on diagnosis and treatment of pediatric chronic pancreatitis[J]. Chin Pediatr Emerg Med, 2023, 30( 7): 504- 507. DOI: 10.3760/cma.j.issn.1673-4912.2023.07.006. 秦秀敏, 张晶, 于飞鸿, 等. 内镜下逆行胰胆管造影术在儿童慢性胰腺炎中的应用价值[J]. 中国小儿急救医学, 2023, 30( 7): 504- 507. DOI: 10.3760/cma.j.issn.1673-4912.2023.07.006.
[47]	RAPHAEL KL, WILLINGHAM FF. Hereditary pancreatitis: Current perspectives[J]. Clin Exp Gastroenterol, 2016, 9: 197- 207. DOI: 10.2147/CEG.S84358.
[48]	FU HX, XU C, TIAN Y, et al. Curative effect of total pancreatectomy and autologous islet transplantation for chronic pancreatitis in children[J/OL]. Chin J Hepat Surg(Electronic Edition), 2022, 11( 2): 118- 122. DOI: 10.3877/cma.j.issn.2095-3232.2022.02.002. 傅红兴, 许昌, 田阳, 等. 全胰腺切除联合自体胰岛移植治疗儿童慢性胰腺炎疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11( 2): 118- 122. DOI: 10.3877/cma.j.issn.2095-3232.2022.02.002.
[49]	SUN ZL. Research progress of total pancreatectomy with islet autotransplantation for chronic pancreatitis or recurrent acute pancreatitis[J]. Chin J Dig Surg, 2023, 22( 5): 599- 603. DOI: 10.3760/cma.j.cn115610-20230406-00155. 孙兆黎. 全胰腺切除胰岛自体移植治疗慢性或复发性急性胰腺炎的研究进展[J]. 中华消化外科杂志, 2023, 22( 5): 599- 603. DOI: 10.3760/cma.j.cn115610-20230406-00155.

Relative Articles

[1]	Lulu ZHOU, Bing DONG, Jiejing XIN, Guanghua XU, Na LIU. Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2025, 41(1): 52-56. doi: 10.12449/JCH250108
[2]	Zhaofang BAI, Xiaoyan ZHAN, Guiji LYU, Yongping YANG. Blocking and reversing liver fibrosis with traditional Chinese medicine compound prescriptions: Beyond the known frontiers[J]. Journal of Clinical Hepatology, 2023, 39(2): 273-277. doi: 10.3969/j.issn.1001-5256.2023.02.004
[3]	Huanming XIAO, Meijie SHI, Yubao XIE, Xiaoling CHI. Advances and thoughts in traditional Chinese medicine diagnosis and treatment of chronic hepatitis B-related liver fibrosis[J]. Journal of Clinical Hepatology, 2023, 39(2): 260-266. doi: 10.3969/j.issn.1001-5256.2023.02.002
[4]	Bibi XUAN, Yonghong XU, Zhongcai DU, Yu LIU, Yuling YANG, Cheng BIAN. Influencing factors for low-level viremia in patients with chronic hepatitis B or hepatitis B liver cirrhosis and its association with the progression of liver inflammation and liver fibrosis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2252-2259. doi: 10.3969/j.issn.1001-5256.2022.10.011
[5]	Hailin CHENG, Xudong HU, Bing XIA, Tao BAI, Sixia LU. Clinical effect of tenofovir alafenamide fumarate on chronic hepatitis B patients with low viral load after entecavir treatment[J]. Journal of Clinical Hepatology, 2022, 38(3): 537-540. doi: 10.3969/j.issn.1001-5256.2022.03.009
[6]	Huikun ZHOU, Jianning JIANG, Minghua SU, Rongming WANG, Bobin HU, Deli DENG, Huilan WEI, Xianshuai LIANG, Wenming HE, Rongsheng GUO. Efficacy of entecavir versus tenofovir disoproxil fumarate in treatment of chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2022, 38(3): 532-536. doi: 10.3969/j.issn.1001-5256.2022.03.008
[7]	Jing LU, Hongxin PIAO, Xuemei JIN, Jingshu CUI, Renshun JIN. Correlation of quality of life with aspartate aminotransferase-to-platelet ratio index, liver stiffness measurement, and histopathology after antiviral therapy for chronic hepatitis B liver fibrosis[J]. Journal of Clinical Hepatology, 2021, 37(4): 813-816. doi: 10.3969/j.issn.1001-5256.2021.04.018
[8]	Ye HaiWen, Deng Yong, Zhang LingQiang, Wang HaiJiu, Zhou Ying, Xu XiaoLei, Fan HaiNing. Influence of HBV DNA load on surgical outcome of hepatitis B-associated liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(9): 1995-1998. doi: 10.3969/j.issn.1001-5256.2018.09.035
[9]	Gu JiuLian, Liu ShouSheng, Li ChangFei, Xiao JianHan, Xin YongNing, Xuan ShiYing. Value of highly sensitive serum virological markers in hepatitis B patients with a low viral load[J]. Journal of Clinical Hepatology, 2018, 34(6): 1302-1307. doi: 10.3969/j.issn.1001-5256.2018.06.037
[10]	Qin XiaoMei, Fan ChenYing, Li ShuangJie, Peng HuiYun. Correlation of HBV DNA load with liver pathology,liver function,and serological markers of liver fibrosis in children with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(3): 472-475. doi: 10.3969/j.issn.1001-5256.2016.03.014
[11]	Li Qiang, Huang YuXian, Chen Liang. Independent predictive factors for significant liver histological changes in patients with HBe Ag-positive high-viral-load chronic HBV infection and a normal alanine aminotransferase level[J]. Journal of Clinical Hepatology, 2016, 32(7): 1310-1314. doi: 10.3969/j.issn.1001-5256.2016.07.019
[12]	Sun JianMin. Efficacy of thymosin α1 in chronic HBV infection patients with low viral load in immune-clearance or low-replication phase[J]. Journal of Clinical Hepatology, 2015, 31(2): 202-204. doi: 10.3969/j.issn.1001-5256.2015.02.014
[13]	Liu HaoGang, Xin YongNing, Jiang Man, Zhang DingDing, Jiang XiangJun, Xuan ShiYing. Correlation between expression of PI4KA in serum and HVB DNA load in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(2): 132-135. doi: 10.3969/j.issn.1001-5256.2014.02.009
[14]	Ding Chen, Pan Fan, Hu HaiZhang, Xiong RiHui, Li Song, Jiang Yi, Pan Chen. Efficacy of antiviral therapy in hepatocellular carcinoma patients with high HBV DNA levels after radical resection[J]. Journal of Clinical Hepatology, 2014, 30(7): 656-659. doi: 10.3969/j.issn.1001-5256.2014.07.021
[15]	Zhang HengBing. Effects of marine in the treatment of chronic hepatitis B patients with low viral load[J]. Journal of Clinical Hepatology, 2012, 28(3): 176-178.
[16]	Niu ChunYan, Gao BaoHua, Zheng JianYun, Wu FangXiong, Wang Wen, Luo JianMei, Zheng NaiQing. The correlations between HBV quantity in the liver tissue and the severity of liver tissue injury in chronic hepatitis B and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 277-279.
[17]	Jiang WeiPing, Lai LiYing, Li XinHua, Chen DongPing. Study on the linkage between variation of YMDD in hepatitis B virus and hepatic fibrosis serum markers[J]. Journal of Clinical Hepatology, 2004, 20(6): 345-346.
[18]	Yin ChiBiao, Zhang FuChun, Xian JianZhong, Cao Yang, Tang XiaoPing. Study of relationship between the serum viral load and ALT level and response to interferon therapy.[J]. Journal of Clinical Hepatology, 2004, 20(2): 97-98.
[19]	Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33.
[20]	Zhang ChunLan, Shi YaLing. The Relation of Hepatic Fibrosis Indexes to HBVDNA Title and Pathological Change[J]. Journal of Clinical Hepatology, 2000, 16(4): 220-221.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	邱功钦，谢丹，陈姿任，欧阳石. 高敏PCR在HBV极低病毒载量的慢性乙型肝炎患者中检测的临床意义. 临床肝胆病杂志. 2024(03): 483-488 . 本站查看
2.	蔡晓娟，汪美华，毛莉萍，缪幼菡，姚超，朱晓红. 恩替卡韦序贯联合聚乙二醇干扰素α-2b治疗低水平HBsAg阳性CHB患者疗效观察. 中西医结合肝病杂志. 2024(07): 587-591 .
3.	安国兴. 慢性乙型肝炎经恩替卡韦治疗后发生低病毒血症的影响因素分析. 医药前沿. 2024(21): 25-27 .
4.	胡兄. 乙型肝炎病毒载量对慢性乙型肝炎患者血清免疫学指标及肝纤维化指标的影响. 慢性病学杂志. 2024(10): 1494-1496+1500 .
5.	熊敏，郭道宁，刘红佶，冯齐齐. 超声弹性成像参数联合血清学指标对不同Child-Pugh分期肝病的诊断价值分析. 现代消化及介入诊疗. 2023(09): 1161-1165 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (291) PDF downloads(25)